Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer

Gene Therapy

Volumn 8, Issue 6, 2001, Pages 431-441

  Pastorino, S ^a   Massazza, S ^a   Cilli, M ^b   Varesio, L ^a   Bosco, M C ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Gene therapy; In vivo transduction; Macrophages; Retrovirus

Indexed keywords

DRUG VEHICLE; GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOENGINEERING; CELL LINE; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENOME; HELPER VIRUS; HOST CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MACROPHAGE; MARKER GENE; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; RETROVIRUS; T LYMPHOCYTE; TUMOR; VIRUS RECOMBINANT; VIRUS TITRATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LUMINESCENT PROTEINS; MACROPHAGES; MICE; MICROSCOPY, FLUORESCENCE; RETROVIRIDAE; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

ANIMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0035065543     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301405     Document Type: Article

References (49)

1. Gene therapy-promises, problems and prospects
2. Retrovirus-mediated gene transfer in cancer therapy
3. Retroviral vectors for use in human gene therapy for cancer, Gaucher disease, and arthritis
4. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients
5. Gene therapy of human severed combined immunodeficiency (SCID)-XI disease
6. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes
7. Gene therapy for cancer: What have we done and where are we going?
8. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors
9. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
10. Transduction of glioma cells using a high-titer retroviral vector system and their subsequent migration in brain tumors
11. Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus
12. A murine macrophage cell line, immortalized by v-raf and v-myc oncogene exhibited normal macrophage differentiated functions
13. Immortalization of macrophages from mouse bone marrow and fetal liver
14. Macrophages and cancer
15. Macrophages in viral infections
16. Role of cytokines in the activation of monocytes
17. Involvement of inflammatory mediators in macrophage antitumor activity
18. The origin and function of tumor-associated macrophages
19. The basis for the immunoregulatory role of macrophages and other accessory cells
20. Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophages colony-stimulating factor and interferon-γ
21. Phase I trial of adoptive immunotherapy of cancer patients using monocytes-derived macrophages activated with interferon-γ and LPS
22. Adoptive immunotherapy of cancer using monocyte-derived macrophages: Rationale, current status, and perspective
23. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens
24. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express INFγ, IL4, IL6, or TNFα
25. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas
26. Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1)
27. Retrovirally mediated IFN-β transduction of macrophages induces resistance to HIV, correlated with up-regulation of RANTES production and down-regulation of C-C chemokine receptor-5 expression
28. Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells
29. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
30. Introduction of DNA into mammalian cells
31. Green fluorescent protein retroviral vectors: Low titer and high recombination frequency suggest a selective disvantage
32. Lack of expression from a retroviral vector after transduction of murine hematopoietic cells is associated with methylation
33. Genetically modified skin fibroblast persist long after transplantation but gradually inactivate introduced genes
34. Generation of high titre, helper-free retroviruses by transient transfection
35. Cell-surface receptors for retroviruses and implications for gene transfer
36. Gene transfer by retrovirus vector occurs only in cells that are actively replicating at the time of infection
37. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages
38. An essential contribution by IFN-γ to CD8+ T cell-mediated rejection of pancreatic islet allografts
39. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats
40. An experimental model of retrovirus gene therapy for malignant brain tumors
41. Intrathecal gene therapy for malignant leptomeningeal neoplasia
42. Gene therapy of hepatoma: Bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir
43. Generation of a high retroviral vector for endothelial cell-specific gene expression in vivo
44. Transplantation of retroviral producer cells for in vivo gene transfer into mouse skeletal muscle
45. Distribution of peritoneal macrophage populations after intravenous injection in mice
46. Migration of human dendritic cells after injection in patients with metastatic malignancies
47. Mature monocytic cells enter tissues and engraft
48. Targeting widespread sites of damage in dystrophic muscle: Engrafted macrophages as potential shuttles
49. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter